After the FDA declined to approve Lykos Therapeutics’ MDMA-assisted therapy for post-traumatic stress disorder, companies are ...

MDMA-assisted psychotherapy has been shown to be a safe and effective treatment for PTSD and complex trauma. Why did the FDA ...

The results showed that patients in the MDMA groups experienced a more significant reduction in PTSD symptom severity compared to those in the placebo groups. The FDA Advisory Committee expressed ...

Brain damage that veterans suffered from flying shrapnel has provided a major clue that could lead to better treatment for ...

See Also: FDA Rejects MDMA For PTSD Treatment, Calls For More Research On Psychedelic Therapy For advocates of psychedelic medicine, this rejection is a major setback. April Pride, CEO and founder ...

"Unfortunately, people sometimes assume PTSD has to do with how mentally ... Americans caring for ill or disabled veteran FDA rejects MDMA to treat post-traumatic stress disorder Researchers ...

MDMA-assisted therapy ... time is a luxury that many patients with PTSD cannot afford. In recent years, the mental health industry has increasingly turned to FDA-cleared, neuroscience-based ...

The U.S. Food and Drug Administration (FDA) has issued a complete response letter for MDMA-assisted psychotherapy (MDMA-AT) for treating post-traumatic stress disorder (PTSD) in which it calls for ...

Recommended Reading In tone-setting verdict, FDA rejects MDMA as a therapy aid for PTSD The CEO of Lykos Therapeutics will step down after the company’s efforts to win a milestone approval for ...